Identification of phages against Clostridium perfringens isolated from diarrhea cases of Humans

Main Article Content

Sidra Nosheen, Dr. M. Aamir Aslam, Muhammad Salman Anwar, Nisha Javed, Nishat Zafar

Keywords

BHI, Clostridium perfringens, RCM

Abstract

Clostridium perfringens is a gram positive, rod shaped, anaerobic and spore forming bacteria. It causes diarrhea among humans which lead towards the severe health and economic losses worldwide. It is also an important pathogen which causes the food born and gas gangrene illness in both humans and animals. Alternative therapies are required for the cure of the bacterial infections because of the increase in antimicrobial resistance in bacteria. Now a day’s bacteriophages play a key role for the curing of bacterial infections that are resistant to antibiotics.


Aim of the study: The objective of this study was to isolate Clostridium perfringens from the clinical cases of diarrhea from individuals and to identify bacteriophages against the diarrhea causing Clostridium perfringens strain.  Materials and methods: A total of 10 feces samples were collected from the diarrhea clinical cases of different individuals from Allied Hospital Faisalabad. RCM, BHI and 5% defibrinate sheep blood agar were used for Clostridium perfringens isolation and the biochemical tests were performed for further confirmation of the bacteria. Bacteriophages were isolated from the diarrhea cases of humans and its lytic activity was examined against the Clostridium perfringens through the spot test technique and agar overlay method. Results: Out of these 10 clinical specimens, Clostridium perfringens was isolated in 6(60%) samples. It showed blackening in RCM broth, turbidity in BHI broth and beta hemolysis occurred in Blood agar. Conclusion: Routine periodic sampling of faeces would facilitate the selection of appropriate method. Clostridium perfringens were isolated and bacteriophages were identified against it

Abstract 104 | pdf Downloads 120

References

1. Ackermann, H.W. 2003. Bacteriophage observations and evolution. Res. Microbiol. 154:245–251.
2. Ackermann, H.-W. 2006. Classification of bacteriophages. The Bacteriophages. 635:12–15.
3. Briggs, D.C., C.E. Naylor, J.G. Smedley, N. Lukoyanova, S. Robertson, D.S. Moss, B.A.
4. Jorge EV, Joshua RS and Adrian CR, 2015. The CpAL Quorum Sensing System Regulates Production of Hemolysins CPA and PFO To Build Clostridium perfringens Biofilms. JASM 83(6):2430-2442.
5. Labbe, R.G. and V.K. Juneja. 2013. Clostridium perfringens gastroenteritis. In: Foodborne Infections and Intoxications (Fourth Edition), Elsevier, 99–112.
6. Li, J., V. Adams, T.L. Bannam, K. Miyamoto, J.P. Garcia, F.A. Uzal, J.I. Rood and B.A. McClane. 2013. Toxin plasmids of Clostridium perfringens. Microbiol. Mol. Biol. Rev. 77:208–233.
7. McClane, B.A. 2003. Clostridium perfringens. In: International Handbook of Foodborne Pathogens, CRC Press, 111–124.
8. Myers, G.S.A., D.A. Rasko, J.K. Cheung, J. Ravel, R. Seshadri, R.T. DeBoy, Q. Ren, J. Varga, M.M. Awad, L.M. Brinkac, S.C. Daugherty, D.H. Haft, R.J. Dodson, R. Madupu, W.C. Nelson, M.J. Rosovitz, S.A. Sullivan, H. Khouri, et al. 2006. Skewed genomic variability in strain of the toxigenic bacterial pathogen, Clostridium perfringens. Genome Res. 16:1031–1040.
9. Ross WM, James S, Alexander S, at al., 2010. Bacteriophage Therapy for Control of Necrotic Enteritis of Broiler Chickens Experimentally Infected with Clostridium perfringens. Avi Dise 54:33-40.
10. Stevens, D.L., M.J. Aldape and A.E. Bryant. 2012. Life-threatening clostridial infections. Anaerobe. 18:254–259.
11. Uzal, F.A., J.C. Freedman, A. Shrestha, J.R. Theoret, J. Garcia, M.M. Awad, V. Adams, R.J. Moore, J.I. Rood and B.A. Mcclane. 2014. Towards an understanding of the role of Clostridium perfringens toxins in human and animal disease. Future Microbiol. 9:361–377.